News | December 30, 2014

Zoll to Acquire Advanced Circulatory Systems Inc.

Acquisition will broaden product offerings with additional technologies designed to improve outcomes from cardiac arrest and other critical conditions

Hemodynamic support devices, Resuscitation Devices, Zoll Medical Corp.

Image courtesy of Advanced Circulatory Systems

December 30, 2014 — Zoll Medical Corp. announced that it will acquire Advanced Circulatory Systems Inc.

Founded in 1997, Advanced Circulatory Systems’ technologies use the body’s own mechanisms to enhance circulation without the use of pharmaceutical or other agents. The vendor’s device uses a facemask with a regulator system to increase or decrease interior chest pressure during normal respiration or CPR to improve the heart’s ability to enhance pre-load and cardiac output. Multiple studies have demonstrated how Advanced Circulatory Systems’ technologies may assist in increasing circulation, cardiac output and systolic blood pressure.

Advanced Circulatory Systems’ Intrathoracic Pressure Regulation (IPR) therapy platform has far-reaching implications for multiple medical conditions. This non-invasive therapy can potentially protect the heart, brain and other vital organs when blood flow is compromised, giving rescuers, clinicians and caregivers the potential to return patients to a full life after critical medical emergencies.

Zoll anticipates the transaction will close in early 2015. Advanced Circulatory Systems will continue to operate out of Minnesota as a part of Zoll’s Core Products division.

For more information: www.advancedcirculatory.com, www.zoll.com

Related Content

Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD)| August 29, 2017
Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left...
Sponsored Content | Videos | Cardiovascular Ultrasound| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD)| June 30, 2017
Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the...
Italian Boy Becomes Youngest Patient Bridged to Transplant With SynCardia Total Artificial Heart

Andrei, 12, is the world’s youngest patient to be bridged to transplant with the SynCardia Total Artificial Heart. He is pictured after his heart transplant with his surgeon, Antonio Amodeo, M.D., at Bambino Gesù Children’s Hospital in Rome, Italy. Photo courtesy of Business Wire.

News | Congenital Heart| June 22, 2017
A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s youngest patient to be...
IABP recall for Maquet, Datascope intra-aortic balloon pump CS100 and CS300

The Datascope CS300 IABP console.

News | Hemodynamic Support Devices| June 20, 2017
June 20, 2017 — The U.S.
Abiomed Impella CP pVAD, third-generation CP
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — Abiomed Inc.
Impella CP study to investigate door to left ventricular unloading time
News | May 09, 2017
May 9, 2017 — The first patient has been enrolled in the U.S.
Heartware HVAD recall for its ventricular assist device from Medtronic
Feature | Ventricular Assist Devices (VAD)| May 05, 2017
May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist De
Technology | Intra-Aortic Balloon Pumps (IABP)| May 02, 2017
May 2, 2017 — The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the Teleflex Inc.
the Impella pVAD improves survival, mortality in AMI heart attack with cardiogenic shock

Early use of the Impella percutaneous ventricular assist device prior to angioplasty may significantly improve survival for patients in cardiogenic shock.

Feature | Hemodynamic Support Devices| April 28, 2017 | Dave Fornell
Recent clinical study data presented at the American College of Cardiology (ACC) 2017 meeting show new treatment prot
Overlay Init